Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.380
-0.270 (-16.36%)
Nov 6, 2026, 1:57 PM EST - Market open

Serina Therapeutics Revenue

In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth. That makes Serina Therapeutics the 45,851st largest company in the world by revenue and 6,730th in the United States.

Revenue (ttm)
$130.00K
Revenue Growth
+132.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
35.05M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025130.00K74.00K132.14%
Dec 31, 202456.00K-3.10M-98.22%
Dec 31, 20233.15M3.12M9,173.53%
Dec 31, 202234.00K-110.00K-76.39%
Dec 31, 2021144.00K-217.00K-60.11%
Dec 31, 2020361.00K-1.37M-79.11%
Dec 31, 20191.73M332.00K23.78%
Dec 31, 20181.40M-8.00K-0.57%
Dec 31, 20171.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Actinium Pharmaceuticals35.09M
Apollomics8.84M
Alterity Therapeutics2.50M
ImageneBio800.00K
INmune Bio50.00K
eXoZymes-700.00
Revenue Rankings